Farmaceutica R (RMAH) — Net Asset Momentum
Farmaceutica R (RMAH) recorded a net asset momentum of 8.1% as of September 2025, with net assets of RON80.99 Million RON. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check tangible equity quality of Farmaceutica R to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Farmaceutica R Net Asset Momentum (2020–2025)
This chart tracks Farmaceutica R's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is +8.1%, with net assets of RON80.99 Million RON as of September 2025. Read debt load of Farmaceutica R for a breakdown of total debt and financial obligations.
Annual Net Asset History for Farmaceutica R (2020–2025)
The table below shows the complete annual net asset history for Farmaceutica R from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see RMAH market cap.
| Year | Net Assets (RON) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | RON80.99 Million | RON384.68 Million | RON303.69 Million | ▲ +8.1% |
| 2024 | RON74.94 Million | RON376.03 Million | RON301.09 Million | ▲ +5.8% |
| 2023 | RON70.86 Million | RON315.76 Million | RON244.90 Million | ▲ +3.5% |
| 2022 | RON68.43 Million | RON286.20 Million | RON217.77 Million | ▲ +0.3% |
| 2021 | RON68.22 Million | RON251.07 Million | RON182.85 Million | ▼ -14.5% |
| 2020 | RON79.83 Million | RON244.46 Million | RON164.63 Million | — |